Oropharyngeal candidiasis in HIV+ patients may influence the selection of HIV-1 protease variants

被引:4
作者
Hickman, PJ
Leigh, JE
Mera, RM
Fidel, PL
Luftig, RB
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Gen Dent, New Orleans, LA 70112 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70112 USA
关键词
HIV-1; protease; oral samples; tissue-specificity;
D O I
10.1016/S0168-1702(01)00428-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Approximately 500 HIV-1 protease gene (pro) sequences were obtained from oral tissues (gingival cuff, buccal mucosa, tongue, palate) as well as saliva and peripheral blood mononuclear cells (PBMC) of 80 HIV-1 positive patients by nested amplification and manual sequencing of PCR products. By visual inspection each patient in this study exhibited a unique sequence profile. HIV-1 pro sequences obtained from patients with oropharyngeal candidiasis (OPC+ patients) had significantly higher numbers of mutations than sequences from OPC- patients, but OpC(+) patients were no more likely to accumulate protease inhibitor resistance mutations than OPC- patients. Although the sequences for each patient were predominantly consistent between PBMC and oral tissues, approximately 10% of the patients demonstrated tissue specificity, and patients that demonstrated tissue specificity tended to be OPC+. Furthermore, HIV-1 pro sequences derived from OPC lesions demonstrated unique mutations in approximately 30% of the patients who provided paired OPC+/- samples of the same tissue type. These data provide evidence for minimal compartmentalization of HIV-1 in oral tissues, yet some patients demonstrate minor variation between the HIV-1 pro sequences obtained from an OPC lesion and those obtained from a non-lesion site of similar tissue. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 22 条
[1]   Production of doughnut-shaped, protease-defective particles from a human T cell clone carrying a provirus with specific mutations in the env, pol, vpr, and nef genes [J].
Bahmani, MK ;
Kameoka, M ;
Nakaya, T ;
Fujinaga, K ;
Zhong, Q ;
Takahashi, H ;
Nakano, T ;
Nakai, M ;
Ueda, S ;
Jones, IM ;
Luftig, RB ;
Ikuta, K .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (06) :523-526
[2]   Randomised trials in ovarian cancer: trial design considerations [J].
Brady, MF ;
Thigpen, JT ;
Vermorken, JB ;
Parmar, MKB .
ANNALS OF ONCOLOGY, 1999, 10 :75-82
[3]   Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor [J].
Condra, JH ;
Holder, DJ ;
Schleif, WA ;
Blahy, OM ;
Danovich, RM ;
Gabryelski, LJ ;
Graham, DJ ;
Laird, D ;
Quintero, JC ;
Rhodes, A ;
Robbins, HL ;
Roth, E ;
Shivaprakash, M ;
Yang, T ;
Chodakewitz, JA ;
Deutsch, PJ ;
Leavitt, RY ;
Massari, FE ;
Mellors, JW ;
Squires, KE ;
Steigbigel, RT ;
Teppler, H ;
Emini, EA .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8270-8276
[4]  
FIDEL PL, 2000, 4 INT WORKSH OR MAN
[5]   PCR AMPLIFICATION OF HIV-1 PROTEINASE SEQUENCES DIRECTLY FROM LAB ISOLATES ALLOWS DETERMINATION OF 5 CONSERVED DOMAINS [J].
FONTENOT, G ;
JOHNSTON, K ;
COHEN, JC ;
GALLAHER, WR ;
ROBINSON, J ;
LUFTIG, RB .
VIROLOGY, 1992, 190 (01) :1-10
[6]   A GENERAL-MODEL FOR THE SURFACE GLYCOPROTEINS OF HIV AND OTHER RETROVIRUSES [J].
GALLAHER, WR ;
BALL, JM ;
GARRY, RF ;
MARTINAMEDEE, AM ;
MONTELARO, RC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (02) :191-202
[7]   Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro [J].
Gruber, A ;
Speth, C ;
Lukasser-Vogl, E ;
Zangerle, R ;
Borg-von Zepelin, M ;
Dierich, MP ;
Würzner, R .
IMMUNOPHARMACOLOGY, 1999, 41 (03) :227-234
[8]   Positive and negative aspects of the human immunodeficiency virus protease: Development of inhibitors versus its role in AIDS pathogenesis [J].
Ikuta, K ;
Suzuki, S ;
Horikoshi, H ;
Mukai, T ;
Luftig, RB .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2000, 64 (04) :725-+
[9]   Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis [J].
Janini, LM ;
Pieniazek, D ;
Peralta, JM ;
Schechter, M ;
Tanuri, A ;
Vicente, ACP ;
DelaTorre, N ;
Pieniazek, NJ ;
Luo, CC ;
Kalish, ML ;
Schochetman, G ;
Rayfield, MA .
VIRUS GENES, 1996, 13 (01) :69-81
[10]   Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: A pilot study in HIV-positive individuals with oropharyngeal candidiasis [J].
Leigh, JE ;
Steele, C ;
Wormley, FL ;
Luo, W ;
Clark, RA ;
Gallaher, W ;
Fidel, PL .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (04) :373-380